Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Aug. 25, 1998

Pfizer selects LTB4 antagonist for clinical testing

Aug. 25, 1998

Japanese lab describes new agents for asthma and inflammation

Aug. 25, 1998

Sankyo describes NK1/NK2 antagonists for treating asthma

Aug. 25, 1998

First European filing for TOBI

Aug. 24, 1998

Tanabe Seiyaku team identifies new candidates for asthma

Aug. 21, 1998

More PDE4 inhibitors described by Byk Gulden

Aug. 20, 1998

TA-270 inhibits the immediate and late asthmatic response and blocks DTH in animal studies

Aug. 19, 1998

SynPhar's HLE inhibitors show unique potential in preventing lung injury

Aug. 18, 1998

Two new series of PDE4 inhibitors reported by Byk Gulden

Aug. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026